Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a ...

Dexcom meanwhile currently occupies around 74% of the CGM market share in the US, according to analysis by GlobalData. The diabetes company also announced its 2025 outlook at the JP Morgan 2025 ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...

Recent advancements include earlier-than-expected progress on the G7 15-day sensor and potential FDA approval for hospital-based use. The firm highlighted growing confidence in DexCom’s multi ...

Meanwhile, Dexcom continues to advance its G7 platform ... Sayer said there’s plenty of room to grow with insulin users who still don’t use CGM, calling it a “huge opportunity.” With that, the company ...

This condition primarily affects people with diabetes, particularly those who use insulin or certain oral medications that stimulate insulin release. However, it can occasionally occur in people ...

A well-known method to counteract low blood sugar is the 15-15 Rule: Check Your Blood Sugar: If possible, use a blood glucose meter to confirm your blood sugar level is below 70 mg/dL (3.9 mmol/L).